- Report
- September 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- July 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- July 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- July 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- June 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- June 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Directory
- June 2026
Global
From €1760EUR$1,950USD£1,525GBP
- Newsletter
- June 2026
Global
€2703EUR$2,995USD£2,342GBP
- Report
- February 2026
- 130 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- December 2025
- 36 Pages
Global
From €2662EUR$2,950USD£2,307GBP
- Report
- November 2025
- 135 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- October 2025
- 80 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- October 2025
- 89 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- August 2025
- 115 Pages
Global
From €3113EUR$3,450USD£2,698GBP
- Report
- June 2025
- 193 Pages
Global
From €4467EUR$4,950USD£3,871GBP
- Report
- June 2025
- 105 Pages
Global
From €3113EUR$3,450USD£2,698GBP
- Report
- June 2025
- 180 Pages
Global
From €3610EUR$4,000USD£3,128GBP
- Report
- April 2026
Middle East, Africa
From €4331EUR$4,799USD£3,753GBP
- Report
- August 2025
- 200 Pages
United States
From €2247EUR$2,490USD£1,947GBP
- Report
- October 2025
- 150 Pages
Middle East
From €5369EUR$5,950USD£4,653GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more